Soluble E-cadherin: More than a symptom of disease

Frontiers in Bioscience

Volumn 17, Issue 5, 2012, Pages 1948-1964

  Grabowska, Magdalena M ^a   Day, Mark L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

ADAM; Biomarker; Cancer; Disease; MMP; Review; Soluble E cadherin

Indexed keywords

BACTERIA (MICROORGANISMS);

CADHERIN;

ANIMAL; DISEASE COURSE; HUMAN; METABOLISM; REVIEW;

ANIMALS; CADHERINS; DISEASE PROGRESSION; HUMANS;

EID: 84859237507     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4031     Document Type: Article

References (101)

1. M. Overduin, T. S. Harvey, S. Bagby, K. I. Tong, P. Yau, M. Takeichi, M. Ikura: Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267, 386-389 (1995).
2. Titus J. Boggon, John Murray, Sophie Chappuis-Flament, Ellen Wong, Barry M. Gumbiner, Lawrence Shapiro: CCadherin Ectodomain Structure and Implications for Cell Adhesion Mechanisms. Science 296, 1308-1313 (2002). (Pubitemid 34522784)
3. P. J. Kilshaw: Alpha E beta 7. Mol Pathol 52, 203-207 (1999). (Pubitemid 29369205)
4. Carsten Grundemann, Monika Bauer, Oliver Schweier, Nanette von Oppen, Ute Lassing, Philippe Saudan, Karl- Friedrich Becker, Klaus Karp, Thomas Hanke, Martin F. Bachmann, Hanspeter Pircher: Cutting Edge: Identification of E-Cadherin as a Ligand for the Murine Killer Cell Lectin-Like Receptor G1. J Immunol 176, 1311-1315 (2006). (Pubitemid 43134270)
5. Masayuki Ito, Takuma Maruyama, Naotoshi Saito, Satoru Koganei, Kazuo Yamamoto, Naoki Matsumoto: Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 203, 289-295 (2006). (Pubitemid 43290837)
6. Seiko Nakamura, Kimiko Kuroki, Izuru Ohki, Kaori Sasaki, Mizuho Kajikawa, Takuma Maruyama, Masayuki Ito, Yosuke Kameda, Mitsuhiko Ikura, Kazuo Yamamoto, Naoki Matsumoto, Katsumi Maenaka: Molecular Basis for E-cadherin Recognition by Killer Cell Lectin-like Receptor G1 (KLRG1). J Biol Chem 284, 27327-27335 (2009).
7. Yih-Tai Chen, Daniel B. Stewart, W. James Nelson: Coupling Assembly of the E-Cadherin/Beta-Catenin Complex to Efficient Endoplasmic Reticulum Exit and Basal-lateral Membrane Targeting of E-Cadherin in Polarized MDCK Cells. J Cell Biol 144, 687-699 (1999). (Pubitemid 29234547)
8. Valeri Vasioukhin, Christoph Bauer, Mei Yin, Elaine Fuchs: Directed Actin Polymerization Is the Driving Force for Epithelial Cell-Cell Adhesion. Cell 100, 209-219 (2000). (Pubitemid 30064909)
9. Frauke Drees, Sabine Pokutta, Soichiro Yamada, W. James Nelson, William I. Weis: Alpha-Catenin Is a Molecular Switch that Binds E-Cadherin-beta-Catenin and Regulates Actin-Filament Assembly. Cell 123, 903-915 (2005). (Pubitemid 41721035)
10. Renee C. Ireton, Michael A. Davis, Jolanda van Hengel, Deborah J. Mariner, Kirk Barnes, Molly A. Thoreson, Panos Z. Anastasiadis, Linsey Matrisian, Linda M. Bundy, Linda Sealy, Barbara Gilbert, Frans van Roy, Albert B. Reynolds: A novel role for p120 catenin in Ecadherin function. J Cell Biol 159, 465-476 (2002). (Pubitemid 35332833)
11. Barry M. Gumbiner: Regulation of Cadherin Adhesive Activity. J Cell Biol 148, 399-404 (2000).
12. M.J. Wheelock, C.A. Buck, K.B. Bechtol, C.H. Damsky: Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 34, 187-202 (1987).
13. Wiebke Schirrmeister, Thorsten Gnad, Thomas Wex, Shigeki Higashiyama, Carmen Wolke, Michael Naumann, Uwe Lendeckel: Ectodomain shedding of E-cadherin and c- Met is induced by Helicobacter pylori infection. Exp Cell Res 315, 3500-3508 (2009).
14. Thorsten Maretzky, Felix Scholz, Bente Koten, Ehrhardt Proksch, Paul Saftig, Karina Reiss: ADAM10- Mediated E-Cadherin Release Is Regulated by Proinflammatory Cytokines and Modulates Keratinocyte Cohesion in Eczematous Dermatitis. J Invest Dermatol 128, 1737-1746 (2008). (Pubitemid 351847371)
15. K. Billion, H. Ibrahim, C. Mauch, C. M. Niessen: Increased Soluble E-Cadherin in Melanoma Patients. Skin Pharmacol Physiol 19, 65-70 (2006). (Pubitemid 43725815)
16. Abdo J. Najy, Kathleen C. Day, Mark L. Day: The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor Activation. J Biol Chem 283, 18393-18401 (2008).
17. Jannet Katz, Qiu-Bo Yang, Ping Zhang, Jan Potempa, James Travis, Suzanne M. Michalek, Daniel F. Balkovetz: Hydrolysis of Epithelial Junctional Proteins by Porphyromonas gingivalis Gingipains. Infect Immun 70, 2512-2518 (2002). (Pubitemid 34408395)
18. Shaoguang Wu, Kuei-cheng Lim, Julie Huan, Roxan F. Saidi, Cynthia Sears: Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A 95, 14979-14984 (1998). (Pubitemid 29003742)
19. Vasilena Gocheva, Wei Zeng, Danxia Ke, David Klimstra, Thomas Reinheckel, Christoph Peters, Douglas Hanahan, Johanna A. Joyce: Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20, 543-556 (2006). (Pubitemid 43345321)
20. Sarah K. Johnson, Vishnu C. Ramani, Leah Hennings, Randy S. Haun: Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109, 1811- 1820 (2007). (Pubitemid 46668545)
21. M. Helal Uddin Biswas, Cheng Du, Chuanyou Zhang, Juerg Straubhaar, Lucia R. Languino, K. C. Balaji: Protein Kinase D1 Inhibits Cell Proliferation through Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Secretion in Prostate Cancer. Cancer Res 70, 2095-2104 (2010).
22. V. Noe, B. Fingleton, K. Jacobs, H. C. Crawford, S. Vermeulen, W. Steelant, E. Bruyneel, L. M. Matrisian, M. Mareel: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. Journal of Cell Science 114, 111-118 (2001). (Pubitemid 32120080)
23. Andre Lochter, Sybille Galosy, John Muschler, Neal Freedman, Zena Werb, Mina J. Bissell: Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to- Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells. J Cell Biol 139, 1861-1872 (1997). (Pubitemid 28079248)
24. K.H. Lee, E.Y. Choi, M.S. Hyun, B.I. Jang, T.N. Kim, S.W. Kim, S.K. Song, J.H. Kim, J.-R. Kim: Association of Extracellular Cleavage of E-Cadherin Mediated by MMP-7 with HGF-Induced in vitro Invasion in Human Stomach Cancer Cells. Eur Surg Res 39, 208-215 (2007). (Pubitemid 47000367)
25. Gaynor Davies, Wen G. Jiang, Malcolm D. Mason: Matrilysin Mediates Extracellular Cleavage of ECadherin from Prostate Cancer Cells. Clin Cancer Res 7, 3289-3297 (2001).
26. John K. McGuire, Qinglang Li, William C. Parks: Matrilysin (Matrix Metalloproteinase-7) Mediates ECadherin Ectodomain Shedding in Injured Lung Epithelium. Am J Pathol 162, 1831-1843 (2003). (Pubitemid 36613042)
27. Jaime Symowicz, Brian P. Adley, Kara J. Gleason, Jeffrey J. Johnson, Supurna Ghosh, David A. Fishman, Laurie G. Hudson, M. Sharon Stack: Engagement of Collagen-Binding Integrins Promotes Matrix Metalloproteinase-9-Dependent E-Cadherin Ectodomain Shedding in Ovarian Carcinoma Cells. Cancer Res 67, 2030-2039 (2007). (Pubitemid 46424220)
28. Jian-Hong Zuo, Wei Zhu, Mao-Yu Li, Xin-Hui Li, Hong Yi, Gu-Qiang Zeng, Xun-Xun Wan, Qiu-Yan He, Jian-Huang Li, Jia-Quan Qu, Yu Chen, Zhi-Qiang Xiao: Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMTlike phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112, 2508-17 (2011).
29. Marisa D. Covington, Robert C. Burghardt, Alan R. Parrish: Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 290, F43-F51 (2006).
30. Orlando D. Gil, Catherine Lee, Edgardo V. Ariztia, Feng-Qiang Wang, Phillip J. Smith, Joanie Mayer Hope, David A. Fishman: Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecol Oncol 108, 361-369 (2008).
31. Filip Ryniers, Christophe Stove, Marc Goethals, Liesbeth Brackenier, Veerle Noe, Marc Bracke, Joel Vandekerckhove, Marc Mareel, Erik Bruyneel: Plasmin Produces an E-Cadherin Fragment That Stimulates Cancer Cell Invasion. Biol Chem 383, 159-165 (2002). (Pubitemid 34224038)
32. Philippe Marambaud, Junichi Shioi, Geo Serban, Anastasios Georgakopoulos, Shula Sarner, Vanja Nagy, Lia Baki, Paul Wen, Spiros Efthimiopoulos, Zhiping Shao, Thomas Wisniewski, Nikolaos K. Robakis: A presenilin- 1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21, 1948-1956 (2002). (Pubitemid 34437192)
33. Alexi Kiss, Regina B. Troyanovsky, Sergey M. Troyanovsky: p120-Catenin Is a Key Component of the Cadherin-gamma-Secretase Supercomplex. Mol Biol Cell 19, 4042-4050 (2008).
34. Emma C. Ferber, Mihoko Kajita, Anthony Wadlow, Lara Tobiansky, Carien Niessen, Hiroyoshi Ariga, Juliet Daniel, Yasuyuki Fujita: A Role for the Cleaved Cytoplasmic Domain of E-cadherin in the Nucleus. J Biol Chem 283, 12691-12700 (2008).
35. Jonathan Rios-Doria, Mark L. Day: Truncated Ecadherin potentiates cell death in prostate epithelial cells. Prostate 63, 259-268 (2005). (Pubitemid 40571060)
36. Ulrike Steinhusen, Jorg Weiske, Volker Badock, Rudolf Tauber, Kurt Bommert, Otmar Huber: Cleavage and Shedding of E-cadherin after Induction of Apoptosis. J Biol Chem 276, 4972-4980 (2001)
37. Dylan R. Edwards, Madeleine M. Handsley, Caroline J. Pennington: The ADAM metalloproteinases. Mol Aspects Med 29, 258-289 (2008).
38. Sophia B. Lee, Anja Schramme, Kai Doberstein, Reinhard Dummer, Mohamed S. Abdel-Bakky, Sascha Keller, Peter Altevogt, Shin T. Oh, Jorg Reichrath, Daniel Oxmann, Josef Pfeilschifter, Daniela Mihic-Probst, Paul Gutwein: ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma. J Invest Dermatol 130, 763-773 (2009).
39. Tetsuro Yoshimura, Toshihiko Tomita, Michael F. Dixon, Anthony T. R. Axon, Philip A. Robinson, Jean E. Crabtree: ADAMs (A Disintegrin and Metalloproteinase) Messenger RNA Expression in Helicobacter pylori- Infected, Normal, and Neoplastic Gastric Mucosa. J Infect Dis 185, 332-340 (2002). (Pubitemid 34107246)
40. Takashi Arima, Hideki Enokida, Hiroyuki Kubo, Ichiro Kagara, Ryouichirou Matsuda, Kazuki Toki, Hiroaki Nishimura, Takeshi Chiyomaru, Shuichi Tatarano, Toshihiko Idesako, Kenryu Nishiyama, Masayuki Nakagawa: Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci 98, 1720- 1726 (2007). (Pubitemid 47487907)
41. Richard J. Lamont, Howard F. Jenkinson: Life Below the Gum Line: Pathogenic Mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 62, 1244-1263 (1998). (Pubitemid 28558298)
42. Jannet Katz, Vijaya Sambandam, John H. Wu, Suzanne M. Michalek, Daniel F. Balkovetz: Characterization of Porphyromonas gingivalis-Induced Degradation of Epithelial Cell Junctional Complexes. Infect Immun 68, 1441-1449 (2000). (Pubitemid 30108542)
43. Boris Turk, Vito Turk: Lysosomes as Suicide Bags in Cell Death: Myth or Reality? J Biol Chem 284, 21783-21787 (2009).
44. Anna Vreemann, Hong Qu, Kristina Mayer, Louise Bjorkholt Andersen, M. Irina Stefana, Sven Wehner, Mariola Lysson, Anca M. Farcas, Christoph Peters, Thomas Reinheckel, Jorg Kalff, Klaudia Brix: Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-traumatic phases. Biol Chem 390, 481-492 (2009).
45. Jianxin Mai, Russell L. Finley, David M. Waisman, Bonnie F. Sloane: Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells. J Biol Chem 275, 12806-12812 (2000). (Pubitemid 30241435)
46. Marco Niedergethmann, Birgit Wostbrock, Jorg W. Sturm, Frank Willeke, Stefan Post, Ralf Hildenbrand: Prognostic Impact of Cysteine Proteases Cathepsin B and Cathepsin L in Pancreatic Adenocarcinoma. Pancreas 29, 204-211 (2004). (Pubitemid 39304977)
47. George M. Yousef, Andreas Scorilas, Angeliki Magklara, Antoninus Soosaipillai, Eleftherios P. Diamandis: The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254, 119-128 (2000).
48. Christopher Mark Overall, Carlos Lopez-Otin: Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2, 657-672 (2002). (Pubitemid 37328917)
49. Dominique Trudel, Yves Fradet, Francois Meyer, Francois Harel, Bernard Tetu: Significance of MMP-2 Expression in Prostate Cancer. Cancer Res 63, 8511-8515 (2003).
50. E. A. Garbett, M. W. R. Reed, N. J. Brown: Proteolysis in human breast and colorectal cancer. Br J Cancer 81, 287-293 (1999). (Pubitemid 29423707)
51. Takayuki Shiomi, Yasunori Okada: MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 22, 145-152 (2003). (Pubitemid 36561054)
52. Kunihiro Hashimoto, Yasunori Kihira, Yuhsi Matuo, Tsuguru Usui: Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate. J Urol 160, 1872-1876 (1998). (Pubitemid 128746778)
53. Kyung Hee Lee, Sang Joon Shin, Kyeong Ok Kim, Min Kyoung Kim, Myung Soo Hyun, Tae Nyeun Kim, Byung Ik Jang, Sang Woon Kim, Sun Kyo Song, Hee Sun Kim, Sung Hwa Bae, Hun Mo Ryoo: Relationship between Ecadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep 16, 823-830 (2006).
54. Wen G. Jiang, Gaynor Davies, Tracey A. Martin, Christian Parr, Gareth Watkins, Malcolm D. Mason, Kefah Mokbel, Robert E. Mansel: Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy. Clin Cancer Res 11, 6012-6019 (2005). (Pubitemid 41170333)
55. Anne M. Manicone, Isham Huizar, John K. McGuire: Matrilysin (Matrix Metalloproteinase-7) Regulates Anti- Inflammatory and Antifibrotic Pulmonary Dendritic Cells That Express CD103 (AlphaEBeta7-Integrin). Am J Pathol 175, 2319-2331 (2009).
56. S. E. Dunsmore, U. K. Saarialho-Kere, J. D. Roby, C. L. Wilson, L. M. Matrisian, H. G. Welgus, W. C. Parks: Matrilysin expression and function in airway epithelium. J Clin Invest 102, 1321-1331 (1998). (Pubitemid 28467560)
57. L. Zhang, J. Shi, J. Feng, H. Klocker, C. Lee, J. Zhang: Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 7, 327-332 (2004). (Pubitemid 41721791)
58. Hanan AlSaeid Alshenawy: Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths. Ann Diagn Pathol 14, 387- 395 (2010).
59. F. Riedel, K. Gotte, J. Schwalb, K. Hormann: Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Anticancer Res 20, 3045-3049 (2000).
60. Bart E. Muhs, George Plitas, Yara Delgado, Ioana Ianus, Jason P. Shaw, Mark A. Adelman, Patrick Lamparello, Peter Shamamian, Paul Gagne: Temporal expression and activation of matrix metalloproteinases-2, - 9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia. J Surg Res 111, 8-15 (2003). (Pubitemid 36808694)
61. B. McMahon, H. C. Kwaan: The Plasminogen Activator System and Cancer. Pathophysiol Haemost Thromb 36, 184-194 (2007).
62. Terri B. Pustilnik, Veronica Estrella, Jon R. Wiener, Muling Mao, Astrid Eder, Mary-Anne V. Watt, Robert C. Bast, Gordon B. Mills: Lysophosphatidic Acid Induces Urokinase Secretion by Ovarian Cancer Cells. Clin Cancer Res 5, 3704-3710 (1999).
63. y. xu, d. c. gaudette, j. d. boynton, a. frankel, x. j. fang, a. sharma, j. hurteau, g. casey, a. goodbody, a. mellors: Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res 1, 1223-1232 (1995).
64. W. Kuhn, B. Schmalfeldt, U. Reuning, L. Pache, U. Berger, K. Ulm, N. Harbeck, K. Spathe, P. Dettmar, H. Hofler, F. Janicke, M. Schmitt, H. Graeff: Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer 79, 1746-1751 (1999). (Pubitemid 29132299)
65. Kiyoharu Ito, Isamu Okamoto, Norie Araki, Yoshiaki Kawano, Mitsuyoshi Nakao, Shigetoshi Fujiyama, Kimio Tomita, Tatsuyuki Mimori, Hideyuki Saya: Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of betacatenin from cell-cell contacts. Oncogene 18, 7080-7090 (1999). (Pubitemid 30028879)
66. A. J. Pittard, R. E. Banks, H. F. Galley, N. R. Webster: Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 76, 629-631 (1996). (Pubitemid 26129534)
67. A. J. Karayiannakis, K. N. Syrigos, A. Savva, A. Polychronidis, G. Karatzas, C. Simopoulos: Serum Ecadherin concentrations and their response during laparoscopic and open cholecystectomy. Surg Endosc 16, 1551-1554 (2002). (Pubitemid 35244865)
68. Taichiro Goto, Akitoshi Ishizaka, Masahiko Katayama, Mitsutomo Kohno, Sadatomo Tasaka, Seitaro Fujishima, Koichi Kobayashi, Hiroaki Nomori: Involvement of Ecadherin cleavage in reperfusion injury. Eur J Cardiothorac Surg 37, 426-431 (2010).
69. Lisa J. McCawley, Lynn M. Matrisian: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13, 534-540 (2001). (Pubitemid 32817010)
70. Mikala Egeblad, Zena Werb: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161-174 (2002). (Pubitemid 37328786)
71. Roberta Mazzieri, Laura Masiero, Lucia Zanetta, Sara Monea, Maurizio Onisto, Spiridione Garbisa, Paolo Mignatti: Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 16, 2319- 2332 (1997). (Pubitemid 27258633)
72. M. Katayama, S. Hirai, K. Kamihagi, K. Nakagawa, M. Yasumoto, I. Kato: Soluble E-cadherin fragments increased in circulation of cancer patients.Br J Cancer 69, 580-585 (1994). (Pubitemid 24076484)
73. Hendrik Streeck, Douglas S. Kwon, Augustine Pyo, Michael Flanders, Mathieu F. Chevalier, Kenneth Law, Boris Julg, Kasper Trocha, Jonathan S. Jolin, Melis N. Anahtar, Jeff Lian, Ildiko Toth, Zabrina Brumme, J. Judy Chang, Tyler Caron, Scott J. Rodig, Danny A. Milner, Alicja Piechoka-Trocha, Daniel E. Kaufmann, Bruce D. Walker, Marcus Altfeld: Epithelial adhesion molecules can inhibit HIV-1-specific CD8+ T-cell functions. Blood 117, 5112-5122 (2011).
74. R. Kuefer, M. D. Hofer, C. S. M. Zorn, O. Engel, B. G. Volkmer, M. A. Juarez-Brito, M. Eggel, J. E. Gschwend, M. A. Rubin, M. L. Day: Assessment of a fragment of ecadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer 92, 2018-2023 (2005). (Pubitemid 40897424)
75. T. R. Griffiths, I. Brotherick, R. I. Bishop, M. D. White, D. M. McKenna, C. H. Horne, B. K. Shenton, D. E. Neal, J. K. Mellon: Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer 74, 579-584 (1996). (Pubitemid 26279053)
76. A.S. Protheroe, R.E. Banks, M. Mzimba, W.H. Porter, J. Southgate, P.N. Singh, M. Bosomworth, P. Harnden, P.H. Smith, P. Whelan, P.J. Selby: Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cance. Br J Cancer 80, 273- 278 (1999). (Pubitemid 29210118)
77. B. Shi, V. Laudon, S. Yu, D. Dong, Y. Zhu, Z. Xu: Ecadherin tissue expression and urinary soluble forms of Ecadherin in patients with bladder transitional cell carcinoma. Urol Int 81, 320-4 (2008).
78. G. Velikova, R. E. Banks, A. Gearing, I. Hemingway, M. A. Forbes, S. R. Preston, N. R. Hall, M. Jones, J. Wyatt, K. Miller, U. Ward, J. Al-Maskatti, S. M. Singh, P. J. Finan, N. S. Ambrose, J. N. Primrose, P. J. Selby: Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 77, 1857-1863 (1996).
79. C. Wilmanns, J. Grossmann, S. Steinhauer, G. Manthey, B. Weinhold, A. Schmitt-Gräff, B. U. von Specht: Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients. Clin Exp Metastasis 21, 75-78 (2004). (Pubitemid 38365660)
80. Y. Chung, S. Law, D. L. W. Kwong, J. M. Luk: Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 24, 49-55 (2011).
81. J. Gofuku, H. Shiozaki, Y. Doki, M. Inoue, M. Hirao, N. Fukuchi, M. Monden: Characterization of soluble Ecadherin as a disease marker in gastric cancer patients. Br J Cancer 78, 1095-1101 (1998). (Pubitemid 28463989)
82. A Chan, S Lam, K Chu, C Lam, E Kwok, S Leung, S Yuen, S Law, W Hui, K Lai, C Wong, H Hu, C Lai, J Wong: Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 48, 808-811 (2001). (Pubitemid 32476983)
83. Annie On On Chan, Kent-Man Chu, Shiu Kum Lam, Kwan Lok Cheung, Simon Law, Ka-Fai Kwok, Wai Man Wong, Man Fung Yuen, Benjamin Chun-Yu Wong: Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer 104, 740-746 (2005). (Pubitemid 41113672)
84. Annie On-On Chan, Kent-Man Chu, Shiu-Kum Lam, Benjamin Chun-Yu Wong, Ka-Fai Kwok, Simon Law, Samuel Ko, Wai-Mo Hui, Yui-Hung Yueng, John Won: Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol 15, 2288-93 (2003 ). (Pubitemid 46621865)
85. Corrado Pedrazzani, Stefano Caruso, Giovanni Corso, Daniele Marrelli, Alessandro Neri, Anna Berardi, Franco Roviello: Influence of age on soluble E-cadherin serum levels prevents its utility as a disease marker in gastric cancer patients. Scand J Gastroenterol 43, 765-766 (2008). (Pubitemid 351868717)
86. Yongning Zhou, Juntao Ran, Chenwei Tang, Jing Wu, Li Honghua, Li Xingwen, Ning Chen, Liang Qiao: Effect of celecoxib on E-cadherin, VEGF, microvessel density and apoptosis in gastric cancer. Cancer Biol Ther 6, 269- 275 (2007). (Pubitemid 46641634)
87. A. Soyama, S. Eguchi, M. Takatsuki, Y. Kawashita, M. Hidaka, H. Tokai, S. Nagayoshi, S. Mochizuki, S. Matsumoto, K. Hamasaki, Y. Tajima, T. Kanematsu: Significance of the serum level of soluble E-cadherin in patients with HCC. Hepatogastroenterology 55, 1390-1393 (2008).
88. K. N. Syrigos, K. J. Harrington, A. J. Karayiannakis, N. Baibas, N. Katirtzoglou, P. Roussou: Circulating Soluble E-Cadherin Levels are of Prognostic Significance in Patients with Multiple Myeloma. Anticancer Res 24, 2027- 2031 (2004). (Pubitemid 38954628)
89. K. Charalabopoulos, A. Gogali, Y. Dalavaga, G. Daskalopoulos, M. Vassiliou, G. Bablekos, A. Karakosta, S. Constantopoulos: The clinical significance of soluble Ecadherin in nonsmall cell lung cancer. Exp Oncol 28, 83-85 (2006).
90. Athena Gogali, Konstantinos Charalabopoulos, Iris Zampira, Athanasios K. Konstantinidis, Fanny Tachmazoglou, George Daskalopoulos, Stavros H. Constantopoulos, Yotanna Dalavanga: Soluble Adhesion Molecules E-Cadherin, Intercellular Adhesion Molecule-1, and E-Selectin as Lung Cancer Biomarkers. Chest 138, 1173-1179 (2010).
91. Karen L. Reckamp, Brian K. Gardner, Robert A. Figlin, David Elashoff, Kostyantyn Krysan, Mariam Dohadwala, Jenny Mao, Sherven Sharma, Landon Inge, Ayyappan Rajasekaran, Steven M. Dubinett: Tumor Response to Combination Celecoxib and Erlotinib Therapy in Nonsmall Cell Lung Cancer Is Associated with a Low Baseline Matrix Metalloproteinase-9 and a Decline in Serum- Soluble E-Cadherin. J Thorac Oncol 3, 117-124 (2008). (Pubitemid 351323184)
92. E. Darai, A. F. Bringuier, F. Walker-Combrouze, G. Feldmann, P. Madelenat, J. Y. Scoazec: Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary. Hum Reprod 13, 2831-2835 (1998). (Pubitemid 28482737)
93. Rainer Kuefer, Matthias D. Hofer, Juergen E. Gschwend, Kenneth J. Pienta, Martin G. Sanda, Arul M. Chinnaiyan, Mark A. Rubin, Mark L. Day: The Role of an 80 kDa Fragment of E-cadherin in the Metastatic Progression of Prostate Cancer. Clin Cancer Res 9, 6447- 6452 (2003). (Pubitemid 38031832)
94. Shigeho Shirahama, Fukumi Furukawa, Hisashi Wakita, Masahiro Takigawa: E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J Dermatol Sci 13, 30-36 (1996). (Pubitemid 26325573)
95. A. Sewpaul, J. J. French, T. K. Khoo, M. Kernohan, J. A. Kirby, R. M. Charnley: Soluble E-Cadherin: An Early Marker of Severity in Acute Pancreatitis. HPB Surg 2009, 6 (2009).
96. Hongjuan Jiang, Guangju Guan, Rui Zhang, Gang Liu, Jing Cheng, Xianghua Hou, Yazhou Cui: Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev 25, 232-241 (2009).
97. Filip Ryniers, Christophe Stove, Marc Goethals, Liesbeth Brackenier, Veerle Noe, Marc Bracke, Joel Vandekerckhove, Marc Mareel, Erik Bruyneel: Plasmin Produces an E-Cadherin Fragment That Stimulates Cancer Cell Invasion. Biological Chemistry 383, 159-165 (2002). (Pubitemid 34224038)
98. Béatrice Nawrocki-Raby, Christine Gilles, Myriam Polette, Erik Bruyneel, Jean-Yves Laronze, Noel Bonnet, Jean-Michel Foidart, Marc Mareel, Philippe Birembaut: Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int J Cancer 105, 790-795 (2003). (Pubitemid 36706102)
99. Landon J. Inge, Sonali P. Barwe, Julia D'Ambrosio, Jegan Gopal, Kan Lu, Sergey Ryazantsev, Sigrid A. Rajasekaran, Ayyappan K. Rajasekaran: Soluble Ecadherin promotes cell survival by activating epidermal growth factor receptor. Exp Cell Res 317, 838-848 (2011).
100. Xiangdong Liu, Jordan S. Fridman, Qian Wang, Eian Caulder, Gengjie Yang, Maryanne Covington, Changnian Liu, Cindy Marando, Jincong Zhuo, Yanlong Li, Wenqing Yao, Kris Vaddi, Robert C. Newton, Peggy A. Scherle, Steven M. Friedma: Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab. Cancer Biol Ther 5, 648-656 (2006). (Pubitemid 44024720)
101. Marcia L. Moss, Martha Bomar, Qian Liu, Harvey Sage, Peter Dempsey, Patricia M. Lenhart, Patricia A. Gillispie, Alexander Stoeck, Dirk Wildeboer, Jorg W. Bartsch, Ralf Palmisano, Pei Zhou: The ADAM10 Prodomain Is a Specific Inhibitor of ADAM10 Proteolytic Activity and Inhibits Cellular Shedding Events. J Biol Chem 282, 35712-35721 (2007). (Pubitemid 350277116)